These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33336620)

  • 1. Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy.
    Kim MJ; Chen G; Sica GL; Deng X
    Cancer Biol Ther; 2021 Jan; 22(1):55-65. PubMed ID: 33336620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization.
    Gao F; Yu X; Li M; Zhou L; Liu W; Li W; Liu H
    Cell Death Dis; 2020 Feb; 11(2):143. PubMed ID: 32081857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer.
    Ye M; Zhang Y; Zhang X; Zhang J; Jing P; Cao L; Li N; Li X; Yao L; Zhang J; Zhang J
    Cancer Res; 2017 Jul; 77(13):3527-3539. PubMed ID: 28522751
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Tong J; Tan S; Nikolovska-Coleska Z; Yu J; Zou F; Zhang L
    Mol Cancer Ther; 2017 Sep; 16(9):1979-1988. PubMed ID: 28619760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer.
    Yu X; Gao F; Li W; Zhou L; Liu W; Li M
    J Exp Clin Cancer Res; 2020 Apr; 39(1):62. PubMed ID: 32276600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.
    Chen G; Park D; Magis AT; Behera M; Ramalingam SS; Owonikoko TK; Sica GL; Ye K; Zhang C; Chen Z; Curran WJ; Deng X
    Cancer Res; 2019 Dec; 79(24):6126-6138. PubMed ID: 31662324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mcl-1 ubiquitination and destruction.
    Inuzuka H; Fukushima H; Shaik S; Liu P; Lau AW; Wei W
    Oncotarget; 2011 Mar; 2(3):239-44. PubMed ID: 21608150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
    Chen MY; Liao WS; Lu Z; Bornmann WG; Hennessey V; Washington MN; Rosner GL; Yu Y; Ahmed AA; Bast RC
    Cancer; 2011 Oct; 117(19):4424-38. PubMed ID: 21491416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trametinib potentiates TRAIL-induced apoptosis via FBW7-dependent Mcl-1 degradation in colorectal cancer cells.
    Lin L; Ding D; Xiao X; Li B; Cao P; Li S
    J Cell Mol Med; 2020 Jun; 24(12):6822-6832. PubMed ID: 32352219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
    Vijayaraghavalu S; Dermawan JK; Cheriyath V; Labhasetwar V
    Mol Pharm; 2013 Jan; 10(1):337-52. PubMed ID: 23215027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer.
    Lemaire M; Chabot GG; Raynal NJ; Momparler LF; Hurtubise A; Bernstein ML; Momparler RL
    BMC Cancer; 2008 May; 8():128. PubMed ID: 18454857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
    Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
    PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mcl-1 inhibition overcomes BET inhibitor resistance induced by low FBW7 expression in breast cancer.
    Wang X; Wei X; Cao Y; Xing P
    J Cell Mol Med; 2022 Mar; 26(5):1672-1683. PubMed ID: 35132755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma.
    Leshchenko VV; Kuo PY; Jiang Z; Weniger MA; Overbey J; Dunleavy K; Wilson WH; Wiestner A; Parekh S
    Oncotarget; 2015 Sep; 6(29):27332-42. PubMed ID: 25714012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.
    Inuzuka H; Shaik S; Onoyama I; Gao D; Tseng A; Maser RS; Zhai B; Wan L; Gutierrez A; Lau AW; Xiao Y; Christie AL; Aster J; Settleman J; Gygi SP; Kung AL; Look T; Nakayama KI; DePinho RA; Wei W
    Nature; 2011 Mar; 471(7336):104-9. PubMed ID: 21368833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non-small cell lung cancer cells via endoplasmic reticulum stress-mediated degradation of Mcl-1.
    Zhang Q; Chen M; Cao L; Ren Y; Guo X; Wu X; Xu K
    Mol Carcinog; 2020 Jun; 59(6):590-603. PubMed ID: 32189414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
    Zhang Y; Zhang X; Ye M; Jing P; Xiong J; Han Z; Kong J; Li M; Lai X; Chang N; Zhang J; Zhang J
    Cancer Lett; 2018 Apr; 419():75-83. PubMed ID: 29355657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.
    Min SH; Lau AW; Lee TH; Inuzuka H; Wei S; Huang P; Shaik S; Lee DY; Finn G; Balastik M; Chen CH; Luo M; Tron AE; Decaprio JA; Zhou XZ; Wei W; Lu KP
    Mol Cell; 2012 Jun; 46(6):771-83. PubMed ID: 22608923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15.
    Ishiguro M; Iida S; Uetake H; Morita S; Makino H; Kato K; Takagi Y; Enomoto M; Sugihara K
    Ann Surg Oncol; 2007 May; 14(5):1752-62. PubMed ID: 17195906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action.
    Petsri K; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31117253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.